News | SPECT-CT | September 07, 2022

Societies outline recommendations for hardware and software, training, competency, cross-specialty and collaboration

Societies Outline Recommendations for Hardware and Software, Training, Competency, Cross-specialty Collaboration, More

September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to answer cardiac imagers’ questions about SPECT/CT and PET/CT imaging with attenuation correction, localization of radiotracer uptake and coronary artery calcium scoring (CACS). In a new multisociety guideline published today in the Journal of Nuclear Cardiology, the organizations recommend training and competency requirements for imaging physicians and technologists; describe models for collaborative, cross-specialty study interpretation and reporting; and suggest solutions for the preauthorization and reimbursement challenges that some labs have faced with hybrid imaging in nuclear cardiology. 

Authored and endorsed by ASNC and the American Association of Physicists in Medicine (AAPM), Society of Cardiovascular Computed Tomography (SCCT) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the new guideline highlights how SPECT/CT and PET/CT testing improve diagnostic accuracy and risk-stratification in patients with known or suspected coronary artery disease as well as the clinical value of hybrid nuclear-CT imaging in assessing infection, inflammation, viability and hibernation in cardiac patients. 

“Hybrid imaging is helping cardiology teams enhance image quality and obtain new information that impact treatment decisions and our patients’ long-term outcomes,” says ASNC President-elect Mouaz H. Al-Mallah, MD, MSc, FASNC, cardiac PET chair at Houston Methodist DeBakey Heart and Vascular Center and the new guideline’s lead author. “Assessing atherosclerosis burden in hybrid imaging improves the diagnostic accuracy of MPI studies and help clinicians identify high-risk patients and treat them accordingly. The question is not whether today’s cardiac imaging labs should adopt hybrid imaging but rather how to adapt their labs for the routine use of SPECT/CT and PET/CT. There are practical day-to-day issues that can become obstacles for labs. We developed this guideline to show the options available for managing the practical issues, thus making hybrid nuclear-CT imaging more accessible for patients who will benefit from it.” 

Imaging teams will find the new guideline is a blueprint for modernizing their labs for the delivery of hybrid nuclear-CT imaging. 

Step by step, the guideline provides detailed discussion, tables and figures explaining – 

  • Hardware, software and image acquisition requirements 
  • Quality control issues, including a list of artifacts that imaging professionals must understand to ensure proper study interpretation and avoid unnecessarily repeated tests 
  • Four study interpretation models that imagers may choose from to ensure the high-quality reading and reporting of extracardiac findings from CT scans performed during hybrid imaging 
  • How to approach standardized integrated hybrid nuclear-CT reports, including the key cardiovascular diagnosis and non-cardiovascular incidental findings that should be reported 
  • Current training and licensing requirements and certification standards for technologists and physicians 
  • Recommendations for competency standards, including necessary skillsets, continuing education credits and case volumes 
  • Coding and billing requirements 
  • How to resolve common preauthorization challenges 

ASNC is committed to providing imagers with the knowledge and tools needed to make their transition to hybrid imaging smooth and successful. The ASNC2022 conference will feature ASNC’s inaugural Hybrid Imaging Symposium, which will examine the key concepts in the new guideline and use real-world cases to demonstrate how imaging professionals can break down technical, training and financial barriers that may be keeping some labs from adopting hybrid nuclear-CT imaging. 

ASNC’s Hybrid Imaging Symposium will be delivered in two parts: 

  • Part 1 is currently available OnDemand on the ASNC2022 online meeting platform. 
  • Part 2 will be delivered live Thursday, Sept. 8, at ASNC2022 in Orlando, Florida. This interactive event will feature a panel of experienced hybrid imagers who have used different hardware, software and models in their labs. 

The 2022 ASNC/AAPM/SCCT/SNMMI Guideline for the Use of CT in Hybrid Nuclear/CT Cardiac Imaging may be downloaded from the Journal of Nuclear Cardiology. 

For more information: www.asnc.org


Related Content

News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | FDA

Oct. 30, 2025 — Sirona Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona ...

Time October 30, 2025
arrow
News | Computed Tomography (CT)

Sept. 29, 2025 — Many studies have shown the inverse relationship between bone mineral density (BMD) — the gold standard ...

Time September 30, 2025
arrow
News | Prostate Cancer

Aug. 13, 2025 — A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer ...

Time August 15, 2025
arrow
News | Mammography

Aug. 5, 2025 — New Lantern has announced the launch of two specialized viewer modes: the Mammography Viewer Mode and PET ...

Time August 05, 2025
arrow
News | Breast Imaging

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has ...

Time July 08, 2025
arrow
News | Image Guided Radiation Therapy (IGRT)

June 25, 2025 — Royal Philips and Indiana-based Methodist Hospitals recently announced the healthcare provider’s ...

Time June 25, 2025
arrow
News | PET Imaging

Jun. 24, 2025 — GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) approved an updated label ...

Time June 24, 2025
arrow
News | PET Imaging

June 19, 2025 – dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a physics ...

Time June 24, 2025
arrow
News | PET-CT

June 23, 2025 — GE HealthCare’s commitment to advancing precision care in cardiology through its molecular imaging ...

Time June 23, 2025
arrow
Subscribe Now